Mildly uncoupling mitochondria reduces myocardial cell injury caused by hypoxia/reoxygenation

Area of Science:

• Cardiology
• Mitochondrial Biology
• Cellular Physiology

Background:

• Ischemia-reperfusion (I/R) injury is a major cause of heart damage with no current treatments.
• Mitochondrial reactive oxygen species (ROS) drive cell injury during I/R.
• Reducing mitochondrial ROS is crucial for mitigating I/R damage.

Purpose of the Study:

• To investigate the protective effects of a low concentration of the mitochondrial uncoupler FCCP on myocardial I/R injury.
• To explore the underlying mechanisms of FCCP's action in cardiac cells.

Main Methods:

• An in vitro myocardial I/R model was established using sodium sulfite-induced hypoxia followed by reoxygenation.
• Cells were treated with 5 nM FCCP to assess its impact on mitochondrial function and injury markers.
• In vivo studies evaluated the protective effects of 1 mg/kg FCCP in an I/R injury model.

Main Results:

• Low-dose FCCP (5 nM) induced uncoupling protein 1 (UCP1) expression in myocardial cells.
• FCCP treatment decreased mitochondrial ROS production and ATP levels.
• FCCP reduced mitophagy and attenuated myocardial injury in both in vitro and in vivo models.

Conclusions:

• Mild mitochondrial uncoupling using low-dose FCCP effectively reduces oxidative stress and myocardial injury.
• FCCP demonstrates therapeutic potential for treating ischemia-reperfusion cardiac damage.